[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.169.191. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 1933

DIRECT COMPARISON BETWEEN SPECIFIC AND NONSPECIFIC SERUM THERAPY FOR TYPE I LOBAR PNEUMONIA

Author Affiliations

BOSTON

From the Thorndike Memorial Laboratory, Second and Fourth Medical Services (Harvard), Boston City Hospital, and the Department of Medicine, Harvard Medical School.

Arch Intern Med (Chic). 1933;51(3):435-446. doi:10.1001/archinte.1933.00150220110008
Abstract

It has been suggested that the effects of specific serum therapy in type I lobar pneumonia are due, not to the specific antibodies contained in the serum, but to the nonspecific action of the intravenously administered horse serum proteins. Miller1 and von den Velden,2 as well as Hallermann and Kähler,3 have made this suggestion because of the symptomatic changes they noted in lobar pneumonia following the injection of protein materials other than immune horse serum, such as typhoid vaccine, normal horse serum and normal human serum. Sonnenfeld4 and Lichtenstein5 have supported this suggestion because they occasionally observed striking clinical improvement in patients with pneumonia due to pneumococci other than type I following the administration of serum that presumably contained only type I pneumococcic antibodies.

An examination of the question from the point of view of those who have had extended experience with the specific serum,

First Page Preview View Large
First page PDF preview
First page PDF preview
×